# The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-affordability-of-lecanemab-an-amyloid-targeting-therapy-for-alzheimer-s/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Linus Jönsson,Anders Wimo,Ron Handels,Gunilla Johansson,Merçé Boada,Sebastiaan Engelborghs,Lutz Frölich,Frank Jessen,Patrick G. Kehoe,Milica G. Kramberger,Alexandre de Mendonςa,Pierre Jean Ousset,Nikolaos Scarmeas,Pieter Jelle Visser,Gunhild Waldemar,Bengt Winblad |
| Citations | 124 |
| DOI | 10.1016/j.lanepe.2023.100657 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.lanepe.2023.100657 |
| OpenAlex ID | https://openalex.org/W4377195480 |
| PMID | 37251789 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Ron Handels](https://scholariq.org/researchers/ron-handels/)

## Paper journal

- [The Lancet Regional Health - Europe](https://scholariq.org/journals/the-lancet-regional-health-europe/)

## Paper primary topic

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Paper topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.